Is Krystal Biotech, Inc. (KRYS) a Buy, Sell, or Hold?
Krystal Biotech, Inc.
NASDAQ:KRYS
$350.24 USD
$10.81 (3.18%)
- Volume
- 381.14K
- Average Volume
- 320.5K
- Market Capitalization
- $10.32B
- P/E Ratio
- 45.19
- Dividend Yield
- 0.00%
- Price Target
- $327.00
- Year High
- $382.54
- Year Low
- $130.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.46
Analyst Rating
Buy
4 Rating Score
UPSIDE/DOWNSIDE
7.1% UPSIDE
$327.00 Price Target
UPSIDE/DOWNSIDE HIGH
-26.1% DOWNSIDE
$474.00 Price Target High
UPSIDE/DOWNSIDE LOW
16.7% UPSIDE
$300.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Joseph Pantginis | $361 | $322.995 | 2026-06-16 09:01 AM | 11.8% |
| Chardan Capital | Geulah Livshits | $323 | $282.6544 | 2026-02-18 07:56 AM | 14.3% |
| Jefferies | Roger Song | $371 | $291.1 | 2026-02-17 01:26 PM | 27.4% |
| Guggenheim | Debjit Chattopadhyay | $224 | $188.33 | 2025-10-17 06:44 AM | 18.9% |
| Stifel Nicolaus | Dae Gon Ha | $220 | $185 | 2024-09-11 02:53 AM | 18.9% |